Peripheral Vascular Disease (PVD) News Peripheral Vascular Disease (PVD) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Hot Chocolate Could Help Ease Painful Clogged Leg Vessels
FRIDAY, Feb. 14, 2020 -- Could hot chocolate deliver relief to those suffering from the painful condition known as peripheral artery disease (PAD)? A small, new study says it ' s entirely possible. Though you may be picturing a steaming cup of hot... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2020 Category: General Medicine Source Type: news

Cocoa may improve lower-leg blood flow, walking in peripheral artery disease
Cocoa may help improve walking and lower-leg blood flow in adults with peripheral artery disease, according to a study published Friday in the journal Circulation Research. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 14, 2020 Category: Consumer Health News Source Type: news

Cocoa may improve leg blood flow, walking in peripheral artery disease
Cocoa may help improve walking and lower-leg blood flow in adults with peripheral artery disease, according to a study published Friday in the journal Circulation Research. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 14, 2020 Category: Consumer Health News Source Type: news

PAD Patients Often Don't Receive Evidence-Based Care From Specialty Clinics PAD Patients Often Don't Receive Evidence-Based Care From Specialty Clinics
Patients with peripheral artery disease (PAD) attending specialty clinics do not always receive evidence-based care, and supervised exercise therapy (SET), in particular, is often missed, an international registry study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Medtech in a Minute: SFA Competition, Check-Cap Inches Toward US Market, and More
Gore Has a New Challenger in SFA PQ Bypass is set to become the first company since 2004 to have an IDE trial for a stent to treat peripheral artery disease in the superficial femoral artery (SFA). If all goes as planned for the company, its Torus Stent Graft will compete head-to-head with W.L. Gore's Viabahn system. PQ Bypass could potentially file for FDA approval in 2021.   Should This Blood Test Be Part of the Standard Pre-Op for Most Surgeries? A common cardiac blood test done before surgery can predict who will experience adverse outcomes after most types of surgery, said researchers from Hami...
Source: MDDI - January 4, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

20 Private Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

20 Private Medtech Companies to Watch in 2020
MD+DI has taken a hard look at the private medtech sector and developed this list of 20 private companies we will be paying particularly close attention to in the new year. It was not an easy task. There are so many interesting private companies in the industry right now that we started with a much longer list and whittled it down to the 20 companies that stood out most to us. So without further ado, here are the 20 companies that made the cut: 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitr...
Source: MDDI - December 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

PQ Bypass Steps into SFA Arena to Compete Against Gore
It might be cliché to say here comes a new challenger – but in the case of PQ Bypass it’s quite true. The Milpitas, CA-based firm said it will be the first company since 2004 to have an IDE trial for a stent to treat peripheral artery disease in the superficial femoral artery (SFA). The other company to have an SFA IDE trial is W.L. Gore. The Newark, DE-based company would eventually win a nod from FDA for the Viabahn system. PQ Bypass made a major advancement in its bid to get the Torus Stent Graft on the market last week as the company reported it received approval for cov...
Source: MDDI - December 23, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

5 More Private Medtech Companies to Keep Tabs On
MedTech analysts continue to keep a watchful eye on the private sector. Needham & Co.'s Mike Matson recently called attention to five private medical device companies he finds interesting, adding to three previous lists the analyst published earlier this year. Matson was not the only medtech analyst keeping tabs on up and coming private companies in 2019. In January, Canaccord Genuity's Jason Mills highlighted 16 potentially disruptive medtech companies in the private sector. Here are the five companies Matson most recently highlighted. 7D Surgical...
Source: MDDI - December 16, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Leg Pain Could Spell Peripheral Artery Disease for Some
FRIDAY, Nov. 29, 2019 -- Leg pain while walking or doing other activities could be a sign of peripheral artery disease, an expert says. Peripheral artery disease (PAD) develops silently, narrowing blood vessels until a shortfall in the supply of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 29, 2019 Category: General Medicine Source Type: news

Medtronic FDA Approval Marks a Turnaround in the Paclitaxel Story
Paclitaxel-coated balloons and paclitaxel-eluting stents caused quite the stir for manufacturers and physicians this year, but an FDA approval this week marks a major step forward for this category of devices. The agency approved Medtronic's IN.PACT AV drug-coated balloon for the treatment of failing arteriovenous access in patients with end-stage renal disease (ESRD) undergoing dialysis. AV fistulae are created and used to enable hemodialysis for patients with ESRD. Over time, vessel restenosis limits the ability to use AV fistulae effectively. In order to restore function, patients often undergo one to three ...
Source: MDDI - November 22, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news

Einstein Awarded $8 Million to Use Wearable Tech to Improve Detection of Leg Arterial Disease
November 21, 2019—(BRONX, NY)—Lower extremity arterial disease (LEAD) is a debilitating but under-recognized condition usually caused by fatty plaque buildup in arteries carrying blood from the heart to the legs. More commonly known as peripheral artery disease, this increasingly common condition affects more than 8 million Americans, including up to 20% of those over the age of 60, and over 200 million people worldwide. Left untreated, LEAD can result in disability, amputations, and death. (Source: Einstein News)
Source: Einstein News - November 21, 2019 Category: Universities & Medical Training Source Type: news

LimFlow Shows ‘PROMISE’ During VIVA
A firm that was labeled one of Medtech’s 16 Most Promising Private Companies by Canaccord Genuity earlier this year, has strong results from a study that will help with FDA approval. LimFlow recently announced positive six-month data from the full patient cohort in its PROMISE I early feasibility study of the Percutaneous Deep Vein Arterialization (pDVA) System. The Paris-based company presented the data during the Vascular Interventional Advances [VIVA] Conference held in Las Vegas, earlier this month. The company’s technology is used for the treatment of chronic limb-threatening ischem...
Source: MDDI - November 18, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Boston Scientific Touts Positive Data on Two Paclitaxel Devices
Boston Scientific announced positive data Tuesday for two paclitaxel devices during separate late-breaking clinical trial presentations at the annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Paclitaxel-coated balloons and paclitaxel-eluting stents caused quite the stir for the drug-coated balloon manufacturers and physicians this year, but presentations like these could go a long way toward helping the market rebound. To recap, paclitaxel balloons and stents received some bad press in late December 2018 after a meta-analysis showed...
Source: MDDI - November 5, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Cardiovascular Source Type: news